- Home
- KNSA vs FBNC Comparison
KNSA vs FBNC Comparison
Compare KNSA & FBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- FBNC
- Stock Information
- Founded
- KNSA 2015
- FBNC 1934
- Country
- KNSA United Kingdom
- FBNC United States
- Employees
- KNSA N/A
- FBNC N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- FBNC Major Banks
- Sector
- KNSA Health Care
- FBNC Finance
- Exchange
- KNSA Nasdaq
- FBNC Nasdaq
- Market Cap
- KNSA 1.9B
- FBNC 2.1B
- IPO Year
- KNSA 2018
- FBNC N/A
- Fundamental
- Price
- KNSA $33.28
- FBNC $52.80
- Analyst Decision
- KNSA Strong Buy
- FBNC Buy
- Analyst Count
- KNSA 6
- FBNC 4
- Target Price
- KNSA $40.83
- FBNC $53.67
- AVG Volume (30 Days)
- KNSA 711.9K
- FBNC 350.3K
- Earning Date
- KNSA 07-29-2025
- FBNC 07-23-2025
- Dividend Yield
- KNSA N/A
- FBNC 1.74%
- EPS Growth
- KNSA N/A
- FBNC N/A
- EPS
- KNSA 0.07
- FBNC 2.35
- Revenue
- KNSA $529,332,000.00
- FBNC $361,053,000.00
- Revenue This Year
- KNSA $37.21
- FBNC $35.55
- Revenue Next Year
- KNSA $6.10
- FBNC $7.19
- P/E Ratio
- KNSA $504.35
- FBNC $22.51
- Revenue Growth
- KNSA 56.18
- FBNC N/A
- 52 Week Low
- KNSA $17.82
- FBNC $34.50
- 52 Week High
- KNSA $33.98
- FBNC $52.92
- Technical
- Relative Strength Index (RSI)
- KNSA 65.73
- FBNC 66.05
- Support Level
- KNSA $31.78
- FBNC $48.76
- Resistance Level
- KNSA $33.66
- FBNC $52.81
- Average True Range (ATR)
- KNSA 1.26
- FBNC 1.56
- MACD
- KNSA 0.24
- FBNC 0.08
- Stochastic Oscillator
- KNSA 90.63
- FBNC 91.96
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About FBNC First Bancorp
First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing and investment advisory services.